Mucosal immunity in COVID-19: a neglected but critical aspect of SARS-CoV-2 infection
MW Russell, Z Moldoveanu, PL Ogra… - Frontiers in …, 2020 - frontiersin.org
The mucosal immune system is the largest component of the entire immune system, having
evolved to provide protection at the main sites of infectious threat: the mucosae. As SARS …
evolved to provide protection at the main sites of infectious threat: the mucosae. As SARS …
COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes
D Focosi, M Franchini, L Pirofski… - Clinical microbiology …, 2022 - Am Soc Microbiol
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …
available as soon as there are survivors. The COVID-19 pandemic represented the first …
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly
infectious respiratory virus which is responsible for the coronavirus disease 2019 (COVID …
infectious respiratory virus which is responsible for the coronavirus disease 2019 (COVID …
[HTML][HTML] Human IgG and IgA responses to COVID-19 mRNA vaccines
AV Wisnewski, JC Luna, CA Redlich - PloS one, 2021 - journals.plos.org
SARS-CoV-2 spike antigen-specific IgG and IgA elicited by infection mediate viral
neutralization and are likely an important component of natural immunity, however, limited …
neutralization and are likely an important component of natural immunity, however, limited …
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
SP Anand, J Prévost, M Nayrac… - Cell Reports …, 2021 - cell.com
With the recent approval of highly effective coronavirus disease 2019 (COVID-19) vaccines,
functional and lasting immunity to severe acute respiratory syndrome coronavirus 2 (SARS …
functional and lasting immunity to severe acute respiratory syndrome coronavirus 2 (SARS …
[HTML][HTML] Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
K Vanshylla, V Di Cristanziano, F Kleipass, F Dewald… - Cell host & …, 2021 - cell.com
Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-
19 pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody …
19 pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody …
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome
Respiratory failure is associated with increased mortality in COVID-19 patients. There are no
validated lower airway biomarkers to predict clinical outcome. We investigated whether …
validated lower airway biomarkers to predict clinical outcome. We investigated whether …
Mucosal vaccines, sterilizing immunity, and the future of SARS-CoV-2 virulence
Sterilizing immunity after vaccination is desirable to prevent the spread of infection from
vaccinees, which can be especially dangerous in hospital settings while managing frail …
vaccinees, which can be especially dangerous in hospital settings while managing frail …
Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 mRNA COVID-19 vaccination
The emergence of effective vaccines for COVID-19 has been welcomed by the world with
great optimism. Given their increased susceptibility to COVID-19, the question arises …
great optimism. Given their increased susceptibility to COVID-19, the question arises …